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SUMMARY
The central nervous and cardiovascular effects of midazolam 0.15 mg kg"1 were studied in 20
healthy, unpremedicated volunteers (10 male and 10 female). No important side-effects were noted
and the venous tolerance to midazolam was excellent. Three minutes after injection mean systolic
arterial pressure decreased from 121±(SEM) 2 mm Hg to 115±(SEM) 2 mm Hg and diastolic
pressure from 78 ± 2 to 70 + 2 mm Hg (P < 0.05), and these effects persisted for at least 20 min.
Heart rate increased from 77 ±4 beat min-1 to 90 ±3 and 88 + 3 beat min"1 1 and 3 min after the
injection (P < 0.05). Anterograde amnesia (40 ± 3 min duration) and drowsiness (lasting 128 ± 23 min)
were observed in all subjects. Loss of the eyelash reflex and apnoea were observed more often in the
male group than in the female subjects. Midazolam 0.15 mg kg"1 was not sufficient to induce
anaesthesia reliably in healthy unpremedicated volunteers.
Midazolam (Ro 21-3981), a new water-soluble
benzodiazepine which can be used for the induction
of anaesthesia, has two important advantages over
diazepam: a short duration of action and absence of
vascular irritation when administered i.v. (Conner,
Katz and Pagano, 1978; Fragen, Gahl and Caldwell,
1978; Reves et al., 1979). The effects of the adminis-
tration of midazolam i.v. on the central nervous and
cardiovascular systems were determined in healthy
volunteers and an assessment of the use of this drug
as an induction agent for general anaesthesia was
made.
SUBJECTS AND METHODS
Twenty volunteers, 10 female and 10 male (mean
age 33±1.5yr (mean ±SEM)), weighing 64.2 +
1.7 kg were studied. Informed consent was obtained
and the committee for ethics in human research of our
institution approved the programme. The subjects
had neither previous medical problem nor took regular
medication or alcohol. Each volunteer was fasted for
at least 12 h before the beginning of the study which
was undertaken before 10 ajn. A Teflon cannula was
inserted in a vein on the dorsum of the left hand and a
solution of 5% dextrose 100 ml h~x was administered.
The e.cg. and arterial pressure (cuff on right arm)
were monitored.
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The subjects rested for 30 min in the supine
position, and then systolic and diastolic arterial
pressures were measured by auscultation (mean
arterial pressure was calculated as diastolic pressure+
one-third of the pulse pressure). Heart rate and
respiratory frequency were determined also. At time
zero midazolam maleate 0.15 mg kg"1 in a 0.25%
solution was injected i.v. over 15 s and the cannula
was flushed using the i.v. infusion while the subject
was asked to count aloud. Arterial pressure, heart rate
and respiratory frequency were measured again at 1,
3, 5 and 20 min after injection of the drug.
The following observations were noted: time to the
onset of dysarthria; time to cessation of counting;
time and duration of disappearance of the eyelash
reflex; onset and duration of apnoea; time of opening
the eyes spontaneously; duration of sleep (time
between injection of the drug and the moment at
which the subjects remained awake and kept the
eyes open without stimulation); duration of subjective
drug effect.
Retrograde amnesia, defined as a lack of recall
before injection, was tested by showing the volunteer
a playing card and a written number 30 s before the
administration of the drug. As soon as the subject
became reusable, he was asked to state the card and
number shown to him before injection.
Anterograde amnesia, defined as a lack of recall
after the administration of the drug, was tested by
showing a card and a number to the volunteer. As
soon as his eyelash reflex had returned he had to
identify them aloud. The recall was tested 1 min
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after the initial presentation. This procedure was
repeated every 5 min, each time with a different num-
ber and card. The time at which the volunteer started
to recall was accepted as being the end of anterograde
amnesia.
A neurological scoring system (table I) was estab-
lished to compare the overall effects of midazolam
on the central nervous system and the differences
between males and females.
TABLE I. Neurological scoring system. Maximum possible score
= 22; minimum possible score = 4
Score
5; •mean^SEM
* ' P<0.05
120-
(1) Duration of dysarthria
(2) Time of cessation of
counting
(3) Loss of eyelash reflex
(4) Apnoea
(5) Duration of closure of eyes
(6) Opening of eyes on command
(7) Duration of sedation
(8) Duration of subjective
effect
(9) Duration of amnesia
<30s
3O-60s
>60s
<100»
100-300 8
>300s
yes
no
yes
no
> 10 min
< 10 min
never closed
yes
no
<30min
30-60 min
>60 min
< 4 h
4-8h
> 8 h
<30min
30-45 min
>45 min
1
2
3
2
1
0
2
0
2
0
2
1
0
0
2
1
2
3
1
2
3
1
2
3
Twenty-two minutes after injection of the drug,
the volunteer was asked to stand up and walk and his
ability was assessed as good, fair or bad. After 60 min,
in order to test the subject's concentration, he was
asked to read a written text aloud. The reading was
assessed good, fair or bad. Twenty-four hours after
the experiment, each volunteer had to signify whether
the experience had been acceptable, fair or un-
acceptable. Signs and symptoms of venous irritation
were sought at 48 h. Statistical analysis was carried
out using the Student's * test and the Chi-square test.
All data are expressed as mean ± SEM.
RESULTS
The cardiovascular effects of midazolam 0.15 mg kg"1
i.v. over 15 s are summarized in figure 1. The systolic
FIG. 1. Variations of systolic (s), mean (m), diastolic (d),
arterial pressures (AP) and heart rate (HR) after i.v. in-
jection of midazolam maleate 0.15 mg k g - 1 in 20 healthy
volunteers.
and diastolic arterial pressures decreased 3 min after
the injection from 121 ±2 to 115±2mmHg and
78 ± 2 to 70 ± 2 mm Hg respectively (P < 0.05). These
decreases in arterial pressure remained constant for
at least 20 min. The heart rate increased 1 min after
the administration of the drug, from 77 ± 4 to 90 +
3 beat min-1 (P<0.05) and lasted for 5 min. When
the subjects were asked to stand up 22 min after the
injection, the mean arterial pressure did not change
significantly (86 ±2 to 82±2mmHg), whereas the
heart rate increased from 78 + 3 to 89 ± 3 beat min-1
(P<0.05).
The effects of midazolam on the central nervous
system are summarized in figure 2. All time data are
related to the time of beginning the injection.
Dysarthria occurred in all volunteers, at a mean time
of 49±4s after injection. Seventeen of the 20
subjects stopped counting at 120± 22 s; the remain-
ing three continued counting for more than 5 min
Ten of the 20 subjects (seven male and three female)
lost the eyelash reflex at 164 ± 42 s, for a duration of
304 ± 104 s. We observed no retrograde amnesia;
every volunteer remembered the card and number
shown to him before the injection. However, antero-
grade amnesia of 40 + 3 min duration occurred in all
MIDAZOLAM AS AN INDUCTION AGENT 909
TIME OF
Dysarthria
Cessation of counting _
Loss of eyelash reflex-
Opening of eyes
Onset of apnoea
DURATION OF
Loss of eyelash reflex -
Drowsiness
Subjective drug ef fect-
Anterograde amnesia -
Apnoea
20
= meant SEM
=mean«-SEM
n= 10
r f n-- 15
n= 8
n= 10
" = 2 0
n =20
n= 20
I
0
I
302 A 6 8 10 20 30 40 50 2 6
Time (min) (h)
FIG. 2. Onset and duration of central nervous effects after i.v. injection of midazolam 0.15 mg kg-1
i.v. in 20 healthy subjects.
10
subjects. Drowsiness lasted for 128 ± 23 min and the
sensation of being under the influence of the drug for
6.7 + 0.8 h. These symptoms were experienced by every
subject. Apnoea occurred in seven of the 10 males and
only in one female at 114 + 19 s and lasted for 30 + 4 s.
Fifteen of the 20 volunteers opened the eyes spon-
taneously 17 ±2 min after the administration of the
drug.
The effects of the drug were said to be acceptable
by 12 of the 20 volunteers and fair by eight others.
Twenty-two minutes after the injection, steadiness
(walking test) was fair in 12 volunteers and good in
eight others. Diplopia occurred in half of the subjects
and lasted for about 20 min. After 1 h concentration
(reading test) was bad in four subjects, fair in four and
good in the other 12. A mild burning at the injection
site was noted on three occasions, but no signs or
symptoms of venous irritation could be found at 48 h.
Males and females responded differently to the
administration of midazolam (fig. 3). The duration of
anterograde amnesia was 46 ± 5 min in males and
33 + 3 min in females. The sensation of being under
the influence of the drug lasted for 8 + 1 h in males
and 5.3 ± 1 h in females; apnoea occurred in 70% of
the male and in only 10% of the female subjects. The
eyelash reflex disappeared in seven of 10 males and
three of 10 females. Nine of 10 males closed the eyes
after the administration of the drug and reopened
them spontaneously after 20 + 3 min, whereas six of
10 females closed them and reopened them after
12 + 3 min. The differences in these data between male
and female subjects are statistically and clinically
significant. If the overall effects on the central nervous
system are compared between males and females
using the neurological score (table I), the male group
had a significantly greater score (16.6+ 1.1) than the
female group (11.0± 1.0).
DISCUSSION
The present study shows that midazolam 0.15 mg
kg"1 produced drowsiness and amnesia in all healthy
young volunteers examined. Other effects on the
central nervous system were not observed repeatedly
(fig. 2). There was no retrograde amnesia, but antero-
grade amnesia similar to that produced by diazepam
(Dundee and Haslett, 1970) was impressive since
none of the subjects remembered standing up and
walking 22 min after the injection. The loss of the
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FIG. 3. Difference of central nervous system effects between
males and females after i.v. injection of midazolam 0.15 mg
kg-1 i.v.
eyelash reflex, a useful sign during the induction of
anaesthesia, was observed in only 50% of the subjects.
These data confirm those of Reves, Corssen and
Holcomb (1978) and suggest that midazolam 0.15 mg
kg"1 is inadequate to induce anaesthesia reliably in
unpremedicated young subjects. It has been shown
that a larger dose (0.2 mg kg"1) provides a satis-
factory induction of anaesthesia in 100% of un-
premedicated patients (Reves, Corssen and Holcomb,
1978).
Our study shows that the i.v. administration of
midazolam 0.15 mg kg"1 produces a statistically
significant but clinically unimportant decrease in
arterial pressure and an increase in heart rate in
healthy volunteers. Other investigations in older but
healthy patients confirm our findings (Conner,
Katz and Pagano, 1978; Fragen, Gahl and Caldwell,
1978). At larger doses or in patients specially at risk
midazolam could possibly cause a greater cardio-
vascular disturbance.
The difference in the sensitivity to midazolam
between males and females was significant for five
important neurological indices (fig. 3) and it was
confirmed by the neurological scoring system applied.
Our study does not provide data to explain this
difference. It could be the result of a true decreased
sensitivity to midazolam or of an increased volume of
distribution in female subjects. This difference
requires investigation and confirmation by further
studies.
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ADMINISTRATION DE MIDAZOLAM PAR
VOIE INTRAVEINEUSE EN TANT QU1 AGENT
D'INDUCTION DE L'ANESTHESIE:
ETUDE EFFECTUEE SUR DES VOLONTAIRES
RESUME
On a itudie sur 20 volontaires (10 homines et 10 femmes) en
bonne santi, n'ayant recu aucune premtdication, let effets
de 0,15 mg kg-1 de midarolam sur le systeme nerveux
central et sur le systeme cardiovasculaire. On n'a remarque
aucun effet secondaire important et la tolerance veineuse au
midazolam a etc excellente. Trois minutes apres rinjecticm,
la pression systolique arterielle moyenne a baisse de 121 mm
Hg±2 (ecart type des moyennes) a 115mmHg±2 (ecart
type des moyennes) et la pression diastolique a diminue
de 78mmHg±2 a 70 mm Hg±2 (f)<0,05) et ces effets
se sont maintenus pendant au moins 20 min. La frequence
cardiaque a augment* de 77 battements min~ l±4 a 90±3
et 88 ± 3 battements min"1; 1 et 3 min apres l'injection
(P<0,05). On a constate sur tous les sujets une amnesic
anterograde (d'une duree de 40 min ± 3 min) et une
somnolence diurne (durant 128min±23 min). On a
observe plus souvent sur le groupe d'hommes que sur le
groupe de femmes la perte du reflexe de cfllrmrnt et de
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l'apnee. Lemidazolam administre a raison de 0,15 mg kg'1
n'a pas etc suffisant pour induire l'anesthesie d'une maniere
fiable a des volontaires en bonne sante n'ayant recu aucune
premedication.
INTRAVENOSES MIDAZOLAM ZUR
NARKOSEEINLEITUNG: EINE STUDIE AN
FREIWILLIGEN
ZUSAMMENFASSUNG
Die Zentramerven- und Kardiovaskutfrerfekte von 0,15 mg
kg"1 Midazolam wurden an 20 gesunden, nicht vorbehan-
ddtcn Friewflligen (10 m&nnlich, 10 wablich) studiert.
Keine wichtigen Nebenerscheinungen wurden bemerkt,
und die venOse Toleranz auf die Droge war ausgezeichnet.
Drei Minuten nach der Injektion sank der systolische
Arteriendruck von 121 ± (SEM) 2 mm Hg auf 115±
(SEM) 2 mm Hg, und der diastolixche Druck von 78 ± 2 auf
70±2 auf 70±2mmHg (P<0,05), und diese Effekte
dauerten wenigstens 20 min an. Pulaxahl rtieg von 77±4
auf 90±3 und auf 88±3 Schlagemin-1 1 und 3 Minuten
nach der Injektion (P<0,05). Anterograde Amnesic
(40±3 min Dauer) und Schlfifrigkeit (Dauer 128±23 min)
wurden bei alien Fersonen beobachtet. Verlust des Lidre-
flexes und Apnoe wurden bei den Mannern hfiufiger als bei
den Frauen beobachtet. Midazolam in Hohe von 0,15 mg
kg"1 war nicht ausreichend, um bei gesunden, nicht
vorbehandelten Freiwilligen Karkose einzuleiten.
MIDAZOLAM INTRAVENOSA CUAL UN
AGENTE DE INDUCCION DE ANESTESIA:
UN ESTUDIO EFECTUADO CON
VOLUNTARIOS
SUMARIO
Se estudiaron los efectos cardiovasculares y sobre el sistema
nervioso central, de 0,15 mg kg"1 de midazolam en 20
voluntaries sanos y sin previa medication (10 hombres y
10 mujeres). No se apreciaron efectos secundarios impor-
tantes y la tolerancia venosa al midazolam fue excelente.
Tres minutos despues de la inyecrion la prerion sistolica
arterial disminuy6 desde 121±2 mm Hg hasta 115±2 mm
Hg y la presion diastolica disminuyo desde 78±2 mm Hg
hasta 70±2mm Hg (P<0,05) y estos efectos perduraron
durante, por lo menos, 20 minutos. El ritmo cardiaco
aumentb desde 77±4 latidos min"1 hasta 90±3 y 88±3
latidos min-1,1 y 3 win despues de la inyecci6a (P<0,05).
En todos los sujetos se observd amnc«iQ de anterogrado
(40 ± 3 min de duracion) y adormecimiento (durante 128 ± 23
min). En el grupo de hombres se observ6 apnea y perdida
de reflejo en el parpado con mis frecuencia que en las
mujeres. No fueron sufidentcs 0,15 mg kg"1 de midazolam
para inducir una anestesia fiable en voluntarios sanos y sin
previa medicaciin.
